Author

Harry S. Wieand

Observed names: H S Wieand, H. S. WIEAND, H. S. Wieand, H. Sam Wieand, H. Wieand, H.S. Wieand, H.Sam Wieand, HARRY S. WIEAND, Harry Sam Wieand

Institutions: Mayo Clinic, Allegheny General Hospital, North Central Cancer Treatment Group, Fred Hutch Cancer Center, Abramson Cancer Center, University of Pennsylvania

Observed institutions: University of Siena, State University of New York, Mayo Clinic, University of Pittsburgh, SUNY Upstate Medical University, Allegheny General Hospital, North Central Cancer Treatment Group, Fred Hutch Cancer Center, International Drug Development Institute (Belgium), UPMC Hillman Cancer Center, John L. McClellan Memorial Veterans Hospital, NSABP Foundation, Duluth Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Abramson Cancer Center, University of Pennsylvania, Billings Clinic

OpenAlex ID: A5081334147

Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma

1991 · James E. Krook, Charles G. Moertel, et al. · New England Journal of Medicine · 1,879

Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery

1994 · Michael J. O'Connell, James A. Martenson, et al. · New England Journal of Medicine · 1,136

PDF

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

1989 · M A Poon, M J O'Connell, et al. · Journal of Clinical Oncology · 887

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

2005 · Daniel J. Sargent, Harry S. Wieand, et al. · Journal of Clinical Oncology · 715

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

1989 · J A Laurie, C G Moertel, et al. · Journal of Clinical Oncology · 700

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

1997 · M J O'Connell, J A Mailliard, et al. · Journal of Clinical Oncology · 585

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

1998 · M J O'Connell, J A Laurie, et al. · Journal of Clinical Oncology · 417

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

1994 · C L Loprinzi, J A Laurie, et al. · Journal of Clinical Oncology · 384

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

1991 · M A Poon, M J O'Connell, et al. · Journal of Clinical Oncology · 375

Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

1989 · J A Moscow, C R Fairchild, et al. · PubMed · 351

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.

1994 · T R Buroker, M J O'Connell, et al. · Journal of Clinical Oncology · 311

End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

2007 · Daniel J. Sargent, Smitha Patiyil, et al. · Journal of Clinical Oncology · 240

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1990 · Stephen Cullinan, Charles G. Moertel, et al. · Cancer · 206

PDF

Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia

1997 · Lynn C. Hartmann, Loren K. Tschetter, et al. · New England Journal of Medicine · 179

PDF

DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma

1991 · Thomas E. Witzig, Charles L. Loprinzi, et al. · Cancer · 151

PDF

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

1994 · S A Cullinan, C G Moertel, et al. · Journal of Clinical Oncology · 134

Diagnostic and prognostic implicatioins of recurrences in patients with syncope

1987 · Wishwa N. Kapoor, Jacqueline Peterson, et al. · The American Journal of Medicine · 133

A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.

1986 · C G Moertel, J Rubin, et al. · Journal of Clinical Oncology · 133

A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Adjuvant Radiation Therapy and Chemotherapy for Resectable Rectal Cancer

1996 · R. D. Gelber, A. Goldhirsch, et al. · JNCI Journal of the National Cancer Institute · 128

PDF

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.

1993 · T M Pisansky, S S Cha, et al. · Journal of Clinical Oncology · 125

Intraoperative and external beam irradiation ± 5-FU for locally advanced pancreatic cancer

1987 · Leonard L. Gunderson, J.Kirk Martin, et al. · International Journal of Radiation Oncology*Biology*Physics · 118

The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma

1987 · N. A. Scott, L. M. Rainwater, et al. · Diseases of the Colon & Rectum · 107

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma

1988 · Karl C. Podratz, George D. Malkasian, et al. · Gynecologic Oncology · 87

Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01

2004 · R. E. Smith, L. Colangelo, et al. · JNCI Journal of the National Cancer Institute · 77

PDF

Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.

1995 · J H Donohue, S Williams, et al. · Journal of Clinical Oncology · 75

Works count: 61

Citation count: 10,540

H-index: 35

I10-index: 48